Other forms are severe, or later-onset limb–girdle muscular dystrophies (LGMDs), which could also arise from mutations in the dystroglycan (dystroglycanopathies) and in the sarcoglycan (sarcoglycanopathies) genes. This evidence concerns the gene DAG1 and neuromuscular disease caused by qualitative or quantitative defects of alpha-dystroglycan.